Page last updated: 2024-11-06

prednisolone and Hypertrophy, Right Ventricular

prednisolone has been researched along with Hypertrophy, Right Ventricular in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okamura, H1
Goto, Y1
Terashima, M1
Takagi, S1
Ishibashi-Ueda, H1
Nonogi, H1
Kawamura, N1
Tsutsui, H1
Fukuyama, K1
Hayashidani, S1
Koike, G1
Egashira, K1
Abe, Y1
Yamamoto, H1
Tsuneyoshi, M1
Takeshita, A1

Other Studies

2 other studies available for prednisolone and Hypertrophy, Right Ventricular

ArticleYear
Images in cardiovascular medicine. Reversible right ventricular hypertrophy due to cardiac sarcoidosis.
    Circulation, 2005, Jun-14, Volume: 111, Issue:23

    Topics: Adult; Dyspnea; Edema, Cardiac; Electrocardiography; Heart Block; Humans; Hypertrophy, Right Ventric

2005
Severe pulmonary hypertension in a patient with systemic lupus erythematosus and minimal lupus activity.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Anticoagulants; Autoimmune Diseases; Calcium Channel Blockers; Disease Progression; Epoprostenol; Fa

2002